Elevation of circulating adiponectin has shown effectiveness in preventing obesity and related cardiometabolic disorders; therefore, adiponectin is considered a therapeutic target for obesity, diabetes, and endothelial dysfunction [98]. The gene discussed is ADIPOQ; the disease is obesity disorder.